Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group.
暂无分享,去创建一个
P. Tugwell | T. Pincus | O. Gluck | J. Tesser | D. Yocum | R. McKendry | G. Kraag | M. Stein | P. Baker | G. Wells | G. Kraag
[1] P. Tugwell,et al. Combination therapy of cyclosporine with methotrexate and gold in rheumatoid arthritis (2 pilot studies). , 1994, The Journal of rheumatology.
[2] D. Felson,et al. The efficacy and toxicity of combination therapy in rheumatoid arthritis. A meta-analysis. , 1994, Arthritis and rheumatism.
[3] J. Klippel,et al. Second-line drug therapy for rheumatoid arthritis. , 1994, The New England journal of medicine.
[4] T. Pincus,et al. Prediction of Long-Term Mortality in Patients with Rheumatoid Arthritis according to Simple Questionnaire and Joint Count Measures , 1994, Annals of Internal Medicine.
[5] A. Dickens,et al. The European Commission and health care. , 1993, British journal of rheumatology.
[6] J J Anderson,et al. The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials , 1993 .
[7] F. Arellano,et al. Malignancies in rheumatoid arthritis patients treated with cyclosporin A. , 1993, British journal of rheumatology.
[8] P. Wells. Manipulative treatment of the spine. , 1993, British journal of rheumatology.
[9] D. Scott,et al. Antirheumatic drugs: a proposed new classification. , 1993, Arthritis and rheumatism.
[10] P. Tugwell,et al. Cyclosporin A in rheumatoid arthritis: overview of efficacy. , 1993, British journal of rheumatology.
[11] T. Pincus,et al. What is the natural history of rheumatoid arthritis? , 1993, Rheumatic diseases clinics of North America.
[12] G. Panayi,et al. Renal morphology after cyclosporin A therapy in rheumatoid arthritis patients. International Kidney Biopsy Registry of Cyclosporin (Sandimmun) in Autoimmune Diseases. , 1993, British journal of rheumatology.
[13] T. Pincus,et al. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. , 1992, The Journal of rheumatology.
[14] M. Urowitz,et al. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis , 1992 .
[15] M. Urowitz,et al. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. , 1992, Arthritis and rheumatism.
[16] E. Brahn,et al. Suppression of collagen-induced arthritis by combination cyclosporin A and methotrexate therapy. , 1991, Arthritis and rheumatism.
[17] M. Newkirk,et al. Complications of immunosuppression associated with weekly low dose methotrexate. , 1991, The Journal of rheumatology.
[18] T. Pincus,et al. Remodeling the pyramid or remodeling the paradigms concerning rheumatoid arthritis--lessons from Hodgkin's disease and coronary artery disease. , 1990, The Journal of rheumatology.
[19] P. Tugwell,et al. Remodelling the pyramid: the therapeutic target of rheumatoid arthritis. , 1990, The Journal of rheumatology.
[20] F. Wolfe,et al. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. , 1990, The Journal of rheumatology.
[21] P. Tugwell,et al. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis , 1990, The Lancet.
[22] F. Arnett. Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.
[23] H. Paulus,et al. The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis. , 1990, Arthritis and rheumatism.
[24] L. A. Healey,et al. Remodeling the pyramid--a concept whose time has come. , 1989, The Journal of rheumatology.
[25] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[26] P. Tugwell,et al. Methotrexate in Rheumatoid Arthritis: Indications, Contraindications, Efficacy, and Safety , 1987 .
[27] T. J. Breen,et al. Biostatistical Analysis (2nd ed.). , 1986 .
[28] R. Palacios. Cyclosporin A inhibits antigen‐ and lectin‐induced but not constitutive production of interleukin 3 , 1985, European journal of immunology.
[29] T. Waldmann,et al. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Vilček,et al. Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. , 1983, Science.
[31] J. Fries,et al. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. , 1982, The Journal of rheumatology.
[32] O. Steinbrocker,et al. Therapeutic criteria in rheumatoid arthritis. , 1949, Journal of the American Medical Association.